Geoffrey Tranmer is a Tenured Associate Professor in the College of Pharmacy at the University of Manitoba. His research integrates medicinal chemistry, drug discovery, and synthetic organic methodologies, with a focus on flow chemistry and targeted cancer therapies. NSERC Post-Doctoral Fellow, University of Cambridge Post-Doctoral Fellow, Princeton University PhD in Organic Chemistry, University of Guelph BSc (Hons) in Chemistry, Brock University His research explores: Development of flow chemistry techniques to enhance synthetic organic methods Lead generation and optimization in drug discovery Bioconjugation strategies for chemical biology applications Targeted cancer therapies leveraging hypoxia-activated prodrugs Recent publications highlight his work in neurodegenerative disease drug design, biomarker discovery, and sustainable synthesis technologies. Scientific Awards CIHR Project Grant (2024-2029) NSERC Discovery Grant (2023-2028) CIHR Bridge Grant (2022) NSERC Alliance Grant (2020) NSERC Engage Grant (2017) Research Manitoba New Investigator Operating Grant (2017) Dr. Tranmer's industrial experience at Merck Frosst and academic leadership at Manitoba position him uniquely to bridge chemistry-biology-industry collaborations. His lab actively trains graduate students in cutting-edge synthesis platforms.
Stephen A. Boyd is a University Distinguished Professor in the Department of Plant, Soil and Microbial Sciences within Michigan State University's College of Agriculture and Natural Resources. His research spans environmental chemistry and microbiology with a focus on soil systems. His educational background includes a B.S. in Chemistry from Central Michigan University (1975), and M.S. and Ph.D. in Soil Chemistry from Purdue University (1978, 1980). Dr. Boyd's research investigates organic contaminant movement in soil, microbial/catalytic degradation mechanisms, and remediation technologies for contaminated soils/sediments. His work features innovative approaches including chemically modified clays for contaminant sorption and degradation, mechanistic studies of toxicant interactions with natural/modified clays, and development of in-situ soil modification technologies. He extensively examines biodegradation of xenobiotics (particularly PCB reductive dechlorination) and bioavailability of soil-bound contaminants to degrading bacteria. His 15 most recent publications reveal strong trends in clay-based contaminant immobilization, pharmaceutical/water pollutant interactions, dioxin chemistry, and nanomaterial applications for environmental remediation, with dominant fields being environmental chemistry, soil science, and contaminant toxicology. University Distinguished Professor (MSU, 2005) Jackson Award in Soil Science (SSSA, 2004) Highly Cited Researcher (Institute for Scientific Information, 2002) Distinguished Faculty Award (MSU, 2001) Soil Science Research Award (SSSA, 1999) Dr. Boyd has secured significant research funding including a recent $750K USDA grant (2022) for PFAS mitigation research. His laboratory focuses on clay chemistry applications for environmental remediation, with notable breakthroughs in soil cleansing technologies and biochar applications. Current work emphasizes advanced contaminant degradation pathways and practical field applications of his soil modification technologies.
Seth Herzon is the Milton Harris '29 Ph.D. Professor of Chemistry at Yale University, with joint appointments in the Departments of Pharmacology and Therapeutic Radiology at the Yale School of Medicine. He is also a Member of the Yale Cancer Center and co-founder of Modifi Biosciences, which was acquired by Merck in Fall 2024. Herzon joined Yale in 2008 after completing his PhD at Harvard University and an NIH postdoctoral fellowship at the University of Illinois, Urbana-Champaign. Her research focuses on organic synthesis with an emphasis on the molecular mechanisms of action of DNA-damaging compounds, particularly anticancer and microbiome-derived natural products. His laboratory has made significant contributions to understanding colibactin, a gut microbiome metabolite that induces colorectal cancer, and has developed novel chemotherapies targeting DNA repair defects in tumors. His work spans synthetic chemistry, chemical biology, and translational medicine, with projects ranging from total synthesis of complex natural products to developing antibacterial agents. His recent publications reveal a strong trend toward microbiome-cancer interactions, particularly focusing on colibactin's role in carcinogenesis, alongside continued innovation in synthetic methodology and therapeutic development for drug-resistant cancers. His work bridges fundamental chemistry with clinical applications, particularly in cancer therapeutics. Among his numerous accolades are the NSF CAREER Award, Searle Scholar Award, Packard Fellowship, Sloan Fellowship, Arthur C. Cope Scholar Award, and the 2024 Yale Cancer Center Class of '61 Cancer Research Award. He served as Associate Editor for The Journal of Organic Chemistry from 2018-2023 and was a member of the United States Defense Science Study Group from 2018-2019. Herzon has mentored numerous PhD students and postdoctoral researchers who have gone on to successful careers in academia and industry. His laboratory at Yale continues to be at the forefront of chemical research with significant translational impact, particularly in cancer drug discovery. The lab maintains active collaborations with researchers across Yale, including in pharmacology, radiobiology, and cancer biology.
Professor Victor Callan AM is Professor of Leadership and Organisational Change at the University of Queensland Business School within the Faculty of Business, Economics and Law. With over 300 publications to his name, including 179 journal articles, 60 conference publications, and 17 books, he is one of Australia's most recognized researchers in organizational change, leadership performance, and employee training. His influential work has shaped public policy in workforce development, vocational education, and organizational change management. Education: Bachelor (Honours) of Arts, University of New South Wales Doctor of Philosophy, Australian National University Professor Callan's research focuses on two primary areas: organizational change and leadership, with special interest in employees' and leaders' experiences with large-scale change; and employee skills, capabilities and training, examining effective responses to skills development and shortages. His work explores adaptation levels, personal capabilities, communication dynamics, and team processes during organizational transitions. He has pioneered research on maverickism in organizations, investigating how positively deviant change agents drive radical organizational transformations. His recent publications reveal a strong trend toward gender equality research, Indigenous knowledge integration, and maverick leadership. These works span multiple disciplines including organizational behavior, human resource management, vocational education, and leadership studies. His research on workplace gender inequality employs wicked problems frameworks, while his work on Indigenous knowledge holders emphasizes co-creation and positioning as expert researchers. Major Awards and Recognition: Fellow of the Academy of Social Sciences in Australia Fellow of the Queensland Academy of Arts and Sciences Fellow of the Australian Institute of Company Directors Member (AM) of the Order of Australia for significant service to higher education University's Award for Excellence in Higher Degree Research Supervision Two UQ Excellence in Leadership Awards Professor Callan has supervised numerous PhD students across diverse topics including leadership ascension, maverickism, CEO appointments, and organizational change. He has secured substantial research funding, including his 14th Australian Research Council project in 2025 focusing on Indigenous women environmental rangers. His advisory work spans over 100 projects for government departments and international organizations across South Africa, Ghana, Tanzania, Indonesia, Bhutan, Brunei, New Zealand, PNG, and South Pacific countries, addressing employee skills, vocational education, industry closures, and workforce development. He actively contributes to executive education for senior managers globally and has developed strong research, consulting, and industry partnerships. His current teaching focuses on MBA programs and the Bachelor of Advanced Business Honours program at UQ.
Silvia Cavagnero is a Professor in the Department of Chemistry at the University of Wisconsin–Madison, with a research focus on protein folding and misfolding in cellular contexts. Her work integrates biomolecular spectroscopy, chemical biology, and computational methods to address fundamental questions in structural biology. B.S., First University of Rome ‘La Sapienza’ (1988) M.S., University of Arizona (1990) Ph.D., California Institute of Technology (1996) Her research explores the role of molecular chaperones like Hsp70 in protein biogenesis, the development of laser-driven NMR techniques for enhanced sensitivity, and the implications of protein aggregation in neurodegenerative diseases. Key projects include cotranslational folding studies at ribosomal exit tunnels and hyperpolarization methods for low-concentration NMR analysis. The 15 most recent publications highlight interdisciplinary advances in NMR spectroscopy optimization Protein folding kinetics Cryo-EM structural analysis Chaperone-client interactions Hsp70 antimicrobial design Hydration dynamics in folding Scientific contributions include A Prize for Going in Vivo (2017) Recognition for Diversity and Inclusion Efforts Students from the Cavagnero Group have pursued careers in academia, pharmaceutical industries, and national laboratories. Her lab emphasizes interdisciplinary training, blending physical chemistry, biology, and computational analysis.
Julie M. Goddard is a Professor of Food Science at Cornell University , affiliated with the College of Agriculture and Life Sciences and the Department of Food Science . Her research focuses on Biomaterials and Biointerfaces , with emphasis on food quality, safety, and sustainability. She leads the Goddard Research Group, which develops innovative polymeric materials and coatings for food packaging, bioprocessing, and equipment. Key projects include antimicrobial/nonfouling coatings, biocatalytic materials, and active packaging to reduce synthetic additives and food waste. Dr. Goddard holds a Bachelor of Science (1999) and Ph.D. (2008) in Food Science from Cornell University. Her work is supported by grants from USDA NIFA, NIH, NSF, and FFAR. Notable awards include the National Excellence in Multistate Research Award (2019) , APLU Junior Moulton Medal (2015) , and Institute of Food Technologists Young Scientist Award (2013) . Her research spans nonmigratory active packaging (e.g., antioxidant, antimicrobial films), biofilm inhibition , and enzyme immobilization . Recent articles highlight advancements in PETase engineering for microplastic degradation and optimization of curcumin-grafted biodegradable materials. She collaborates across disciplines, including materials science, chemical engineering, and microbiology. Labs/Teams: The Goddard Group operates in Stocking Hall, Cornell. Projects include biocatalytic packaging , hydrogen sulfide formation in canned beverages , and consumer acceptance of novel food technologies . Key grants fund exploration of bio-based materials and food safety innovations.
Anna G Orr serves as Nan and Stephen Swid Assistant Professor of Frontotemporal Dementia Research and Assistant Professor of Neuroscience at Weill Cornell Medical College's Brain and Mind Research Institute since 2016, leading pioneering research on astrocyte biology in dementia pathogenesis. Her educational background includes: Ph.D. from Emory University (2008) B.S. from Allegheny College (2002) Dr. Orr's research program centers on astrocytic-neuronal interactions , mitochondrial signaling , and neuroimmune mechanisms through three interconnected pathways: neuroimmune , oxidative , and G protein-coupled signaling . Her lab investigates how these mechanisms influence neuroinflammation, protein aggregation, synaptic function, and behavioral outcomes in dementia, with parallel therapeutic discovery efforts targeting astrocytic pathways for novel dementia treatments. Analysis of her 15 most recent publications (2025-2010) reveals escalating focus on astrocyte-specific dementia mechanisms , particularly mitochondrial ROS signaling, sex-dimorphic memory effects, TDP-43 pathology interactions with antiviral pathways, and lipid dysregulation in neurodegeneration. Her work consistently bridges molecular discoveries with therapeutic applications, demonstrating increasing NIH funding support for translational approaches. Key scientific recognitions include: NIH K99/R00 Pathway to Independence Award (2017) Leon Levy Fellowship in Neuroscience (2021) Nan and Stephen Swid Endowed Professorship (2021) Outstanding Neuroscience Teaching Award (2021) Dr. Orr actively mentors eight trainees across career stages, including Ph.D. candidates Evelyn Hardin and Constance Zhou, while securing major NIH grants as Principal Investigator for projects like Uncovering Dementia-Related Lipid Alterations in Astrocytes (NIA 2024-2026) and Mitochondrial Complex III Free Radicals in Dementia Pathology (NIA 2020-2026), alongside collaborative awards from the Alzheimer's Association. Her Orr Lab maintains a dual focus on mechanistic astrocyte biology and therapeutic translation, with current projects examining astrocytic TDP-43 dysregulation, mitochondrial complex III signaling, and sex-specific memory mechanisms using advanced in vivo techniques and disease models.
Shabaz Mohammed is an Associate Professor of Proteomics at the University of Oxford, holding joint appointments in the Departments of Chemistry and Biochemistry. Since 2020, he has served as Head of the Mechanistic Proteomics research programme at the Rosalind Franklin Institute. His research focuses on advancing proteomics technologies to study protein post-translational modifications and their roles in cellular processes, with applications in viral infections and disease mechanisms. Education: BSc in Chemistry, UMIST (now The University of Manchester), 1999 PhD in Biological Mass Spectrometry, University of Manchester, 2003 Postdoctoral Research, University of Southern Denmark (with Ole Jensen), 2005-2008 Postdoctoral Research, Utrecht University (with Albert Heck), 2008 Professor Mohammed's research centers on developing novel mass spectrometry approaches for large-scale characterization of protein post-translational modifications (PTMs). His group innovates in chromatographic techniques for single-cell proteomics, creates materials for PTM enrichment (glycosylation/phosphorylation), and applies these tools to study viral infections (SARS-CoV-2), cell cycle regulation, and signaling pathways. His work bridges chemistry, biochemistry, and cell biology to understand dynamic protein functions in health and disease. His recent publications (2023-2025) demonstrate strong emphasis on viral proteomics, particularly virus-host RNA-binding protein interactions, and innovations in mass spectrometry fragmentation techniques and chromatography. Key themes include viral remodeling of host cells, new labeling strategies for PTMs, and advancements in single-cell proteomics, with significant implications for understanding viral pathogenesis. Scientific Awards: No specific awards or fellowships were detailed in the source material. Advising and Grants: Information regarding graduate students supervised or specific research grants was not provided in the available text. As an active research group leader, Professor Mohammed likely mentors PhD students and secures competitive funding for proteomics research. Laboratories and Collaborations: Professor Mohammed leads a research group at Oxford focused on proteomics technology development. He collaborates extensively with the Ben Davis group on PTM detection materials and across the university on biochemical applications. At the Rosalind Franklin Institute, he heads the Mechanistic Proteomics programme to unravel protein functions through advanced proteomic methods.
Prof. Dr. Norbert Sewald, Chair of Organic and Bioorganic Chemistry at Bielefeld University, is a leading figure in Bioorganic Chemistry , Chemical Biology , and Enzymatic Halogenation . As head of the Organic and Bioorganic Chemistry Group at the Center for Biotechnology (CeBiTec), he drives research on natural products and drug conjugates. Full Professor, Bielefeld University (since 1999) Founding Coordinator, International Graduate School of Chemistry and Biochemistry (2001-2003) Chairman, Institute of Biochemistry and Bioengineering at CeBiTec (2006-2008) Dean, Department of Chemistry (2008-2011) Chairman, Max-Bergmann-Kreis e.V. (since 2010) Coordinator, Marie Skłodowska-Curie Training Networks (MAGICBULLET, 2015-2018; Magicbullet::reloaded, 2020-2023) His research focuses on halogenases for mild peptide bromination, cryptophycin-based tumor targeting , and bioactive natural products from African flora. Collaborative projects span antiplasmodial agents , antibacterial compounds , and neurodegenerative disease inhibitors . Recent work highlights include: Enzymatic halogenation cascades Click-to-release drug conjugates Fluorescent probes for amyloid detection Key affiliations: Faculty of Chemistry Center for Biotechnology (CeBiTec) European Peptide Society (Scientific Affairs Officer, 2016-) Leibniz Institute of Plant Biochemistry (Scientific Advisory Board, 2010-2017)
Carlos Diaz Ruiz is an Associate Professor (tenure-track) at the Department of Marketing, Hanken School of Economics in Vasa, Finland. He holds a Ph.D. in Marketing from Finland and has held faculty positions at Hanken, Aalto University, KEDGE Business School (France), and the University of Auckland (New Zealand). His research focuses on market-shaping, consumer culture, and disinformation, particularly in digital advertising and social media contexts. He authored the book *Market-Oriented Disinformation Research: Digital Advertising, Disinformation and Fake News on Social Media* (2025) and received the 2025 Thomas C. Kinnear Award for his work on disinformation in social media echo chambers. Dr. Diaz Ruiz’s academic career includes roles as a Lecturer and Senior Lecturer at the University of Auckland, and prior to academia, he worked as a consumer insights consultant for Latin American companies, recognized in ESOMAR's Insights250 (2022, 2024). He is an Associate Editor at the *Journal of Marketing Management* and actively publishes in top journals like *Journal of Public Policy & Marketing* and *New Media & Society*. His teaching emphasizes bridging academic research with industry needs, offering courses in qualitative research, strategic branding, and consumer culture. Methodologically, he employs business anthropology and ethnography to study consumer-led marketing strategies. Key research themes include the intersection of disinformation, social media business models, and the performative role of market representations.
J.P. Eggers is the Interim Dean and Professor of Management and Organizations at New York University’s Leonard N. Stern School of Business, where he also holds the Catherine & Peter Kellner Professorship of Entrepreneurship. He has been a faculty member since 2008 and served as Vice Dean for MBA and Graduate Programs from 2018 to 2024, leading major innovations in MBA education including the Andre Koo Technology and Entrepreneurship MBA program and the Online-Modular Option for the Langone Part-time MBA. His educational background includes a Ph.D. in Management from the Wharton School at the University of Pennsylvania, an M.B.A. from Goizueta Business School at Emory University, and a B.A. in History from Amherst College. Eggers’ research centers on technological change, decision-making under uncertainty, and new product development. He investigates how firms and executives navigate innovation, make strategic choices amid ambiguity, and respond to technological disruptions. His work spans industries such as video games, mutual funds, flat panel displays, and platform markets, focusing on topics like organizational learning, radical invention, and portfolio expansion strategies. The trends in his recent publications reveal a strong focus on strategic adaptation in evolving industries, emphasizing firm experience, resource constraints, and behavioral factors in innovation. His work frequently appears in top-tier journals such as Strategic Management Journal , Organization Science , and Academy of Management Journal . Poets & Quants Top 40 Professors Under 40 (2011) NYU Stern MBA Program Professor of the Year (2010) Emerald Management Review Citation of Excellence (2010) Business Policy Division of Academy of Management Finalist for Outstanding Dissertation Award (2009) Technology Division of Academy of Management Finalist for Outstanding Dissertation Award (2009) Eggers has a strong record of advising Ph.D. students and securing research support. His leadership roles in academic programs reflect his commitment to experiential learning, innovation in curriculum design, and expanding access to MBA education for working professionals. He has also launched initiatives like SternWorks and the Executive in Residence program to broaden career pathways for MBA students. He is actively involved in research centers and initiatives at Stern, particularly those related to technology, entrepreneurship, and behavioral strategy, though specific lab affiliations are not detailed in the provided text.
Simon Brewster serves as Senior Research Fellow and Consultant Urological Surgeon at the University of Oxford's Hertford College, where he has been Clinical Tutor since 2002 after serving as Lecturer (2002-2011). His clinical work focuses on prostate cancer at Oxford University Hospitals NHS Trust, delivering exam-focused bedside teaching for Years 4-6 medical students. Education: BSc in Anatomy (1st class), Charing Cross Hospital Medical School, 1983 MBBS (Hons. Pathology), Charing Cross Hospital Medical School, 1986 FRCS exams and MD research, Bristol (1988-1998) Brewster's research program demonstrates sequential evolution from basic science (1998-2007) investigating IGF1R targeting and Wnt signaling in prostate cancer to clinical translation (2011-2022) evaluating multiparametric MRI integration in diagnostic pathways and active surveillance protocols. His work bridges laboratory discoveries with patient-centered outcomes, particularly examining how imaging advancements impact treatment decisions and quality of life. The multidisciplinary nature of his clinical research involves close collaboration between urologists, oncologists, radiologists, and pathologists to optimize prostate cancer management. Analysis of his 15 most recent publications reveals three dominant themes: (1) MRI-driven diagnostic refinement including pre-biopsy MRI implementation and active surveillance reclassification, (2) comparative treatment efficacy studies evaluating focal therapy versus radical prostatectomy, and (3) national guideline development through NICE recommendations. His work consistently addresses real-world clinical challenges in prostate cancer management, with strong emphasis on patient satisfaction metrics and practical implementation within the UK healthcare system. Scientific Awards: BJUI Article of the Week (November 18, 2018) for MRI impact on active surveillance As an educator, Brewster has co-supervised four higher research degrees and served as Clinical Supervisor for junior surgical trainees since 1998, including Intercollegiate ISCP Educational Supervisor role since 2009. His grant portfolio includes the UK PART trial (focal therapy vs radical prostatectomy, PI Prof Richard Bryant) and Oxfordshire MRI implementation study (2015-2019). He chairs the Hertford College/Vaughan Williams Prize for Excellence in Clinical Medicine. He leads a multidisciplinary research consortium including Dr. Val Macaulay (basic science) and Prof. W. Bodmer (Wnt pathway research), while coordinating clinical activities through Oxford University Hospitals NHS Trust. His work directly informs national prostate cancer pathways through British Association of Urological Surgeons committees and NICE guideline development.
Jan Christoffer Andersen is a Research Fellow at the Department of Criminology and Sociology of Law , University of Oslo. His research focuses on online radicalization, subcultural dynamics, and masculinity studies, particularly examining the incel community's narratives and social movements. He holds a Master's in Criminology from the University of Oslo, where his thesis on Islamic State propaganda was later published in Terrorism and Political Violence . Andersen has taught courses including KRIM1000, KRIM1100, and KRIM4104. His current PhD project, funded by the University of Oslo, investigates incels' worldview, radicalization processes, and gendered experiences. Methodologically, he employs netnography and qualitative interviews to analyze incel forums and offline experiences. His work challenges monolithic portrayals of incels by emphasizing nuanced narratives around stigma and masculinity. Key research themes include: Incel subculture's structural and individual factors (feminism, dating markets) Intersection of digital spaces and radicalization Counter-narratives in extremism prevention Recent publications explore methodological challenges in studying far-right groups, masculine identity negotiation, and symbolic boundary work within subcultures.
Alistair Sterling is an Assistant Professor in the Department of Chemistry & Biochemistry at the University of Texas at Dallas (UTD), affiliated with the School of Natural Sciences and Mathematics. His research integrates computational modeling, theoretical physical organic chemistry, and electronic structure theory to study chemical reactivity, particularly in catalysis, molecular editing, and polymer upcycling. Sterling leads the Sterling Lab, emphasizing interdisciplinary collaboration with synthetic chemists and fostering skills in reaction mechanism analysis, coding, and scientific communication. He actively engages in outreach to promote public understanding of chemistry. Education includes a DPhil in Organic Chemistry (University of Oxford, 2021), an MChem in Chemistry (University of Oxford, 2017), and postdoctoral fellowships at Lawrence Berkeley National Lab and UC Berkeley. He holds the EPSRC Doctoral Prize Fellowship (2021). Research focuses on understanding chemical bonding and reactivity through computational tools, with applications in drug discovery and sustainable materials. Key themes include delocalization-enabled reactions, node-induced electron confinement, and strain-release mechanisms. The lab develops novel synthetic methods for creating complex molecules with pharmaceutical relevance, such as meta-substituted arene bioisosteres. Notable awards include the Global Young Scientists Summit (2021), Young Modellers' Forum Best Talk Prize (2019), and multiple University of Oxford scholarships. His work bridges theory and experiment, aiming to advance both fundamental understanding and practical innovations in chemistry.
Stephen Levene is a Professor of Bioengineering at The University of Texas at Dallas (UT Dallas), affiliated with the Erik Jonsson School of Engineering and Computer Science. His research focuses on the physical and functional genomics of DNA structure, protein-DNA interactions, and DNA topology in biological systems. He holds a PhD from Yale University (1985) and an AB from Columbia University (1979). Levene’s laboratory investigates genome organization, chromatin dynamics, and the role of circular DNA (eccDNA) in health and disease. His work employs advanced biophysical techniques, including hydroxyl radical probing, gel electrophoresis, and single-molecule analysis. Key areas include DNA supercoiling, topoisomerase function, and the interplay between DNA structure and cellular processes. His research has led to innovations in DNA topology simplification, Cre recombination kinetics, and methodologies for analyzing circular DNA populations in organisms like C. elegans and humans. Levene’s lab also develops tools for genomic studies, such as shallow-learning models for DNA fragmentation analysis and unmasking hidden topological activities in recombination systems. Levene’s contributions span over 40 years, with publications addressing DNA looping, knotting, and the thermodynamics of nucleoprotein assemblies. His work bridges biophysics, molecular biology, and engineering, emphasizing interdisciplinary approaches to genomic challenges.
